WALL STREET GETS OFF EASY –
Dec. 29, 2022 – The federal Controlled Substances Act requires pharmaceutical distributors to monitor their customer orders and notify federal officials of any that may be of unusual size or ordering patterns that could suggest the drugs are being diverted for illegal uses.
During nearly a decade, between 2014 and 2022, the suit alleges, the Pennsylvania-based company did not report hundreds of thousands of suspicious drug orders. For example, AmerisourceBergen distributed drugs to two pharmacies in Florida and West Virginia and allegedly knew that those drugs were likely being sold in parking lots for cash, according to the lawsuit, which was filed in the U.S. District Court for the Eastern District of Pennsylvania.
